Does thrombolysis add value to thrombectomy for acute ischaemic stroke?
- PMID: 37640036
- DOI: 10.1016/S0140-6736(23)01202-3
Does thrombolysis add value to thrombectomy for acute ischaemic stroke?
Conflict of interest statement
GJH reports personal honoraria outside the submitted work from the American Heart Association (as an Associate Editor for Circulation), AC Immune (as a member of the data safety monitoring committee for the ACI-35–1802 trial of immune therapies for Alzheimer's disease), Bristol Myers Squibb (as a member of the steering committee for the AXIOMATIC-SSP trial of milvexian [factor XIa inhibitor] for secondary stroke prevention), and Janssen (as Co-chair of the executive committee for the Librexia Stroke trial of milvexian for secondary stroke prevention).
Comment on
-
Value of intravenous thrombolysis in endovascular treatment for large-vessel anterior circulation stroke: individual participant data meta-analysis of six randomised trials.Lancet. 2023 Sep 16;402(10406):965-974. doi: 10.1016/S0140-6736(23)01142-X. Epub 2023 Aug 25. Lancet. 2023. PMID: 37640037
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
